Many studies have confirmed the effect of insulin on the secretion of pancreatic enzymes in patients with types 1 and 2 of this disease, whose progression leads to morphological changes in the pancreas in the form of steatosis and fibrosis, reduction of organ mass, and disorders of its exocrine function [57]. The gene discussed is INS; the disease is steatosis.